STYK1 enhances the migration, invasion, and EMT of non-small cell lung cancer by inhibiting FoxO1 signaling, increasing the expression of transcription factors Snail1 and zinc finger E-box-binding homeobox 2 (Zeb2), and mesenchymal marker vimentin, and reducing the levels of epithelial marker E-cadherin (Lai et al. 2021). Here, ZEB2 is linked to non-small cell lung carcinoma.